Pinar Zorlutuna
Affiliations: | 2012 | Harvard Medical School, Boston, MA, United States |
Google:
"Pinar Zorlutuna"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Annabi N, Mithieux SM, Zorlutuna P, et al. (2024) Corrigendum to 'Engineered cell-laden human protein-based elastomer' [34 (2013), 5496-5505]. Biomaterials. 308: 122572 |
| Basara G, Bahcecioglu G, Ren X, et al. (2023) An Experimental and Numerical Investigation of Cardiac Tissue-Patch Interrelation. Journal of Biomechanical Engineering. 145 |
| Basara G, Ozcebe SG, Ellis BW, et al. (2021) Tunable Human Myocardium Derived Decellularized Extracellular Matrix for 3D Bioprinting and Cardiac Tissue Engineering. Gels (Basel, Switzerland). 7 |
| Basara G, Saeidi-Javash M, Ren X, et al. (2020) Electrically conductive 3D printed TiCT MXene-PEG composite constructs for cardiac tissue engineering. Acta Biomaterialia |
| Bahcecioglu G, Basara G, Ellis BW, et al. (2020) Breast cancer models: Engineering the tumor microenvironment. Acta Biomaterialia |
| Basara G, Yue X, Zorlutuna P. (2019) Dual Crosslinked Gelatin Methacryloyl Hydrogels for Photolithography and 3D Printing. Gels (Basel, Switzerland). 5 |
| Acun A, Nguyen TD, Zorlutuna P. (2019) In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction. Acta Biomaterialia |
| Contessotto P, Ellis B, Jin C, et al. (2019) Distinct glycosylation in membrane proteins within neonatal versus adult myocardial tissue. Matrix Biology : Journal of the International Society For Matrix Biology |
| Mason DE, Collins JM, Dawahare JH, et al. (2019) YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility. The Journal of Cell Biology |
| Acun A, Zorlutuna P. (2019) CRISPR/Cas9 edited hiPSC-based vascular tissues to model aging and disease-dependent impairment. Tissue Engineering. Part A |